A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease
Clinical trial NCT03707730 · COMPLETED
Trial details
- NCT number
- NCT03707730
- Sponsor
- Igy Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-29
- Primary completion
- 2023-12-31
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.